Ascendis Pharma A/S ASND
-
-
-
已收盤：-
淨值比明細
年季 | 收盤價 | 權益總計(百萬) | 稅後權益報酬率(%) | 稅後純益(百萬) | 稅後資產報酬率(%) | 資產總計(百萬) |
|---|---|---|---|---|---|---|
| 2024Q4 | 137.67 | -106 | -38 | -3.38 | 1,179 | |
| 2024Q3 | 149.31 | -97 | -99 | -10.71 | 1,094 | |
| 2024Q2 | 136.38 | -321 | -109 | -14.02 | 758 | |
| 2024Q1 | 151.17 | -238 | -131 | -16.10 | 803 | |
| 2023Q4 | 125.95 | -146 | -87 | -10.23 | 826 | |
| 2023Q3 | 93.64 | -73 | -162 | -19.12 | 873 | |
| 2023Q2 | 89.25 | 65 | -104.66 | -121 | -13.57 | 824 |
| 2023Q1 | 107.22 | 167 | -111 | 966 | ||
| 2022Q4 | 122.13 | 263 | -58.03 | -207 | -17.55 | 1,090 |
| 2022Q3 | 103.26 | 452 | -31.90 | -169 | -13.00 | 1,273 |
| 2022Q2 | 92.96 | 608 | -12.70 | -81 | -6.01 | 1,327 |
| 2022Q1 | 117.36 | 673 | -16.13 | -125 | -10.19 | 1,377 |
| 2021Q4 | 134.53 | 884 | -11.30 | -106 | -9.26 | 1,085 |
| 2021Q3 | 159.39 | 994 | -9.56 | -80 | -7.81 | 1,205 |
| 2021Q2 | 131.55 | 687 | -18.03 | -134 | -14.79 | 852 |
| 2021Q1 | 128.88 | 803 | -7.65 | -63 | -6.46 | 965 |
| 2020Q4 | 166.78 | 839 | -15.52 | -139 | -13.72 | 980 |
| 2020Q3 | 154.32 | 952 | -17.04 | -122 | -15.15 | 1,046 |
| 2020Q2 | 147.90 | 477 | -95 | 561 |